159 related articles for article (PubMed ID: 8030255)
1. Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides.
Porta C; Spall VE; Loveland J; Johnson JE; Barker PJ; Lomonossoff GP
Virology; 1994 Aug; 202(2):949-55. PubMed ID: 8030255
[TBL] [Abstract][Full Text] [Related]
2. Expression of an animal virus antigenic site on the surface of a plant virus particle.
Usha R; Rohll JB; Spall VE; Shanks M; Maule AJ; Johnson JE; Lomonossoff GP
Virology; 1993 Nov; 197(1):366-74. PubMed ID: 7692669
[TBL] [Abstract][Full Text] [Related]
3. Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus.
Taylor KM; Lin T; Porta C; Mosser AG; Giesing HA; Lomonossoff GP; Johnson JE
J Mol Recognit; 2000; 13(2):71-82. PubMed ID: 10822251
[TBL] [Abstract][Full Text] [Related]
4. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
[TBL] [Abstract][Full Text] [Related]
5. Expression & immunogenicity of malaria merozoite peptides displayed on the small coat protein of chimaeric cowpea mosaic virus.
Yasawardene SG; Lomonossoff GP; Ramasamy R
Indian J Med Res; 2003 Sep; 118():115-24. PubMed ID: 14700344
[TBL] [Abstract][Full Text] [Related]
6. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.
Cañizares MC; Lomonossoff GP; Nicholson L
Expert Rev Vaccines; 2005 Oct; 4(5):687-97. PubMed ID: 16221070
[TBL] [Abstract][Full Text] [Related]
7. Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants.
Gopinath K; Wellink J; Porta C; Taylor KM; Lomonossoff GP; van Kammen A
Virology; 2000 Feb; 267(2):159-73. PubMed ID: 10662612
[TBL] [Abstract][Full Text] [Related]
8. The development of cowpea mosaic virus as a potential source of novel vaccines.
Porta C; Spall VE; Lin T; Johnson JE; Lomonossoff GP
Intervirology; 1996; 39(1-2):79-84. PubMed ID: 8957673
[TBL] [Abstract][Full Text] [Related]
9. Cowpea mosaic virus-based systems for the production of antigens and antibodies in plants.
Liu L; Cañizares MC; Monger W; Perrin Y; Tsakiris E; Porta C; Shariat N; Nicholson L; Lomonossoff GP
Vaccine; 2005 Mar; 23(15):1788-92. PubMed ID: 15734042
[TBL] [Abstract][Full Text] [Related]
10. [Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics].
Meshcheriakova IuA; El'darov MA; Migunov AI; Stepanova LA; Repko IA; Kiselev OI; Lomonosov DP; Skriabin KG
Mol Biol (Mosk); 2009; 43(4):741-50. PubMed ID: 19807038
[TBL] [Abstract][Full Text] [Related]
11. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
[TBL] [Abstract][Full Text] [Related]
12. Display-induced antigenic variation in recombinant peptides.
Carbonell X; Feliu JX; Benito A; Villaverde A
Biochem Biophys Res Commun; 1998 Jul; 248(3):773-7. PubMed ID: 9704003
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5.
Kusov YY; Zamjatina NA; Poleschuk VF; Michailov MI; Morace G; Eberle J; Gauss-Müller V
Antiviral Res; 2007 Feb; 73(2):101-11. PubMed ID: 17014915
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus.
McLain L; Porta C; Lomonossoff GP; Durrani Z; Dimmock NJ
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):327-34. PubMed ID: 7786579
[TBL] [Abstract][Full Text] [Related]
15. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
16. Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials.
Chatterji A; Burns LL; Taylor SS; Lomonossoff GP; Johnson JE; Lin T; Porta C
Intervirology; 2002; 45(4-6):362-70. PubMed ID: 12602357
[TBL] [Abstract][Full Text] [Related]
17. Potential of chimaeric plant virus particles as novel, stable vaccines.
Xu F; Jones TD; Rodgers PB
Dev Biol Stand; 1996; 87():201-5. PubMed ID: 8854018
[TBL] [Abstract][Full Text] [Related]
18. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
de Prat-Gay G
Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic epitopes on the surface of the hepatitis A virus capsid: Impact of secondary structure and/or isoelectric point on chimeric virus assembly.
Kusov Y; Gauss-Müller V; Morace G
Virus Res; 2007 Dec; 130(1-2):296-302. PubMed ID: 17640757
[TBL] [Abstract][Full Text] [Related]
20. [Immunogenetic properties of peptides mimicking a human immunodeficiency virus gp41 (HIV-1) epitope recognized by virus-neutralizing antibody 2F5].
Tumanova OIu; Kuvshinov VN; Orlovskaia IA; Proniaeva TR; Pokrovskiĭ AG; Il'ichev AA; Sandakhchiev LS
Mol Biol (Mosk); 2003; 37(3):556-60. PubMed ID: 12815965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
